CPT1A and colorectal carcinoma: Similarly, exosome-mediated delivery of siRNA against carnitine palmitoyltransferase 1A (CPT1A) enhances the response to oxaliplatin in CRC by inhibiting CPT1A and downstream fatty acid oxidation (FAO) 373.